Comparison Overview

Vertex Pharmaceuticals

VS

Charles River Laboratories

Vertex Pharmaceuticals

Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, US, 02210
Last Update: 2025-12-10
Between 750 and 799

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 6,124
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Charles River Laboratories

251 Ballardvale Street, Wilmington, Massachusetts, US, 01887
Last Update: 2025-12-05
Between 750 and 799

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 14,752
Subsidiaries: 2
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/vertex-pharmaceuticals.jpeg
Vertex Pharmaceuticals
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/charles-river-laboratories.jpeg
Charles River Laboratories
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Vertex Pharmaceuticals
100%
Compliance Rate
0/4 Standards Verified
Charles River Laboratories
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Vertex Pharmaceuticals in 2025.

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Charles River Laboratories in 2025.

Incident History — Vertex Pharmaceuticals (X = Date, Y = Severity)

Vertex Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries

Incident History — Charles River Laboratories (X = Date, Y = Severity)

Charles River Laboratories cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/vertex-pharmaceuticals.jpeg
Vertex Pharmaceuticals
Incidents

No Incident

https://images.rankiteo.com/companyimages/charles-river-laboratories.jpeg
Charles River Laboratories
Incidents

No Incident

FAQ

Charles River Laboratories company demonstrates a stronger AI Cybersecurity Score compared to Vertex Pharmaceuticals company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Charles River Laboratories company has disclosed a higher number of cyber incidents compared to Vertex Pharmaceuticals company.

In the current year, Charles River Laboratories company and Vertex Pharmaceuticals company have not reported any cyber incidents.

Neither Charles River Laboratories company nor Vertex Pharmaceuticals company has reported experiencing a ransomware attack publicly.

Neither Charles River Laboratories company nor Vertex Pharmaceuticals company has reported experiencing a data breach publicly.

Neither Charles River Laboratories company nor Vertex Pharmaceuticals company has reported experiencing targeted cyberattacks publicly.

Neither Vertex Pharmaceuticals company nor Charles River Laboratories company has reported experiencing or disclosing vulnerabilities publicly.

Neither Vertex Pharmaceuticals nor Charles River Laboratories holds any compliance certifications.

Neither company holds any compliance certifications.

Charles River Laboratories company has more subsidiaries worldwide compared to Vertex Pharmaceuticals company.

Charles River Laboratories company employs more people globally than Vertex Pharmaceuticals company, reflecting its scale as a Biotechnology Research.

Neither Vertex Pharmaceuticals nor Charles River Laboratories holds SOC 2 Type 1 certification.

Neither Vertex Pharmaceuticals nor Charles River Laboratories holds SOC 2 Type 2 certification.

Neither Vertex Pharmaceuticals nor Charles River Laboratories holds ISO 27001 certification.

Neither Vertex Pharmaceuticals nor Charles River Laboratories holds PCI DSS certification.

Neither Vertex Pharmaceuticals nor Charles River Laboratories holds HIPAA certification.

Neither Vertex Pharmaceuticals nor Charles River Laboratories holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description

Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.

Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description

The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N